These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24964775)

  • 1. Fractures in children with cerebral palsy.
    Mughal MZ
    Curr Osteoporos Rep; 2014 Sep; 12(3):313-8. PubMed ID: 24964775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased fracture incidence after 1 year of pamidronate treatment in children with spastic quadriplegic cerebral palsy.
    Bachrach SJ; Kecskemethy HH; Harcke HT; Hossain J
    Dev Med Child Neurol; 2010 Sep; 52(9):837-42. PubMed ID: 20573180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone densitometry in pediatric patients treated with pamidronate.
    Grissom LE; Kecskemethy HH; Bachrach SJ; McKay C; Harcke HT
    Pediatr Radiol; 2005 May; 35(5):511-7. PubMed ID: 15655696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005088. PubMed ID: 27760454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis.
    Kim MJ; Kim SN; Lee IS; Chung S; Lee J; Yang Y; Lee I; Koh SE
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1343-50. PubMed ID: 26214607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture after bisphosphonate treatment in children with cerebral palsy: the role of stress risers.
    Harcke HT; Stevenson KL; Kecskemethy HH; Bachrach SJ; Grissom LE
    Pediatr Radiol; 2012 Jan; 42(1):76-81. PubMed ID: 21877116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy.
    Sees JP; Sitoula P; Dabney K; Holmes L; Rogers KJ; Kecskemethy HH; Bachrach S; Miller F
    J Pediatr Orthop; 2016 Mar; 36(2):193-7. PubMed ID: 25757207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of pamidronate for the treatment of osteopenia in non-ambulatory children.
    Henderson R
    Dev Med Child Neurol; 2006 Sep; 48(9):708. PubMed ID: 16904013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to: Zoledronate Increases Bone Mineral Density in Nonambulant Children With Cerebral Palsy: A Randomized, Controlled Trial.
    Trinh A; Milat F
    J Clin Endocrinol Metab; 2023 Dec; 109(1):e418-e419. PubMed ID: 37437090
    [No Abstract]   [Full Text] [Related]  

  • 11. Osteopenia in cerebral palsy.
    Shaw NJ; White CP; Fraser WD; Rosenbloom L
    Arch Dis Child; 1994 Sep; 71(3):235-8. PubMed ID: 7979497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate treatment for children with disabling conditions.
    Boyce AM; Tosi LL; Paul SM
    PM R; 2014 May; 6(5):427-36. PubMed ID: 24368091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study.
    Plotkin H; Coughlin S; Kreikemeier R; Heldt K; Bruzoni M; Lerner G
    Dev Med Child Neurol; 2006 Sep; 48(9):709-12. PubMed ID: 16904014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate treatment of pediatric bone disease.
    Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
    Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate therapy for osteogenesis imperfecta.
    Phillipi CA; Remmington T; Steiner RD
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005088. PubMed ID: 18843680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.
    Reginster JY
    Drugs; 2011 Jan; 71(1):65-78. PubMed ID: 21175240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.
    Angthong C; Rodjanawijitkul S; Samart S; Angthong W
    Acta Orthop Traumatol Turc; 2013; 47(5):318-22. PubMed ID: 24164940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review.
    Mergler S; Evenhuis HM; Boot AM; De Man SA; Bindels-De Heus KG; Huijbers WA; Penning C
    Dev Med Child Neurol; 2009 Oct; 51(10):773-8. PubMed ID: 19614941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy.
    Bachrach SJ; Kecskemethy HH; Harcke HT; Lark RK; Miller F; Henderson RC
    J Clin Densitom; 2006; 9(2):167-74. PubMed ID: 16785077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Question 2: Do standing frames and other related physical therapies reduce the risk of fractures in children with cerebral palsy?
    Whittaker S; Tomlinson R
    Arch Dis Child; 2015 Dec; 100(12):1181-3. PubMed ID: 26586521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.